Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MTE 04 - Radiotherapy for SCLC (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 311 + 312
- Type: Meet the Expert
- Track: Radiotherapy
-
+
MTE 04.01 - Role of Radiotherapy in Multimodality Treatment for SCLC
07:00 - 07:30 | Presenter: Corinne Faivre-Finn
- Abstract
Loading... -
+
MTE 04.02 - General Principles of PCI in the Treatment of SCLC
07:30 - 08:00 | Presenter: David L Ball
- Abstract
Loading...
-
+
MTE 05 - Neuroendocrine Tumors: Pathology and Genetic Update (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 313 + 314
- Type: Meet the Expert
- Track: Biology/Pathology
-
+
MTE 05.01 - Neuroendocrine Tumors: Pathology and Genetic Update
07:00 - 08:00 | Presenter: Elisabeth Brambilla
- Abstract
Loading...
-
+
MTE 06 - Lung Cancer Pathology Update (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 315
- Type: Meet the Expert
- Track: Biology/Pathology
-
+
MTE 06.01 - Lung Cancer Pathology Update
07:00 - 08:00 | Presenter: Andre L. Moreira, Prudence Russell
- Abstract
Loading...
-
+
MTE 07 - Molecular Biology: Minimum Requirement for Clinicians (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 501
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
-
+
MTE 07.01 - Molecular Biology that Clinicians Should Know: From a Clinical Viewpoint
07:00 - 07:30 | Presenter: Prasad S. Adusumilli
- Abstract
Loading... -
+
MTE 07.02 - Molecular Biology that Clinicians Should Know: From a Basic Viewpoint
07:30 - 08:00 | Presenter: Martin Filipits
- Abstract
No abstract available for this presentation
-
+
MTE 08 - Technical Details of EBUS and EUS (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 502
- Type: Meet the Expert
- Track: Pulmonology/Endoscopy
-
+
MTE 08.01 - Technical Aspects of EBUS-TBNA for Clinicians
07:00 - 07:30 | Presenter: Takahiro Nakajima
- Abstract
Loading... -
+
MTE 08.02 - Clinical Aspects of EUS(B)-FNA
07:30 - 08:00 | Presenter: Bin Hwangbo
- Abstract
Loading...
-
+
MTE 09 - Management of Difficult Symptoms (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 503
- Type: Meet the Expert
- Track: Nursing/Palliative Care/Ethics
-
+
MTE 09.01 - Management of Difficult Symptoms
07:00 - 07:30 | Presenter: Richard J Gralla
- Abstract
Loading... -
+
MTE 09.02 - Symptom Experiences and Symptom Clusters in Advanced Lung Cancer
07:30 - 08:00 | Presenter: Sanjay Popat
- Abstract
Loading...
-
+
MTE 10 - Bridging the Gap between Genomics and Clinics (Sign Up Required)
- 07:00 - 08:00
- 10/16/2017
- Location: Room 511 + 512
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
-
+
MTE 10.01 - Bridging the Gap between Genomics and Clinics
07:00 - 07:30 | Presenter: Christian Rolfo
- Abstract
Loading... -
+
MTE 10.02 - Bridging the Gap between Genomics and Clinics
07:30 - 08:00 | Presenter: Julien Sage
- Abstract
Loading...
-
+
PL 01 - Prevention, Screening, and Management of Screen-Detected Lung Cancer
- 08:15 - 09:45
- 10/16/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Radiology/Staging/Screening
- Moderators:Michael Boyer, Matthijs Oudkerk
-
+
PL 01.01 - Current Status of Smoking Cesession Program (Tobacco Control)
08:15 - 08:35 | Presenter: Carolyn Dresler
- Abstract
Loading... -
+
PL 01.02 - Major Advances in CT Screening: A Radiologist's Perspective
08:35 - 08:55 | Presenter: Claudia I Henschke | Author(s): Rowena Yip, Michael Chung, Artit Jirapatnakul, Ricardo S Avila, David F Yankelevitz
- Abstract
Loading... -
+
PL 01.03 - Changing Epidemiology in Lung Cancer
08:55 - 09:15 | Presenter: Mary Reid
- Abstract
No abstract available for this presentation
-
+
PL 01.04 - What is the Optimal Management of Screen-Detected Lung Cancers
09:15 - 09:35 | Presenter: Shun-ichi Watanabe
- Abstract
Loading... -
+
PL 01.05 - Q&A
09:35 - 09:45
- Abstract
No abstract available for this presentation
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-001 - Depth of Target Lesion Response to Brigatinib and Its Association With Outcomes in Patients With ALK+ NSCLC in the ALTA Trial
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): M. Tiseo, Myung-Ju Ahn, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
P1.01-002 - TP53 Mutations Predict for Poor Survival in ALK Rearrangement Lung Adenocarcinoma Patients Treated with Crizotinib
09:30 - 09:30 | Presenter: Gang Chen | Author(s): W. Wang, Chunwei Xu, Y. Chen, Wu Zhuang, G. Lin, X. Chen, B. Wu, Y. Huang, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-004 - Hypertension With Brigatinib: Experience in ALTA, a Randomized Phase 2 Trial in Crizotinib-Refractory ALK+ NSCLC
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): Myung-Ju Ahn, Karen L Reckamp, Howard L West, Rudolf M Huber, Corey J Langer, Lyudmila A Bazhenova, Natasha B Leighl, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
P1.01-005 - Overall Survival (OS) After Disease Progression (PD) on Brigatinib in Patients With Crizotinib-Refractory ALK+ NSCLC in ALTA
09:30 - 09:30 | Presenter: Corey J Langer | Author(s): H. Huang, W. Reichmann, S. Lustgarten, D. Kerstein, D. Ross Camidge
- Abstract
Loading... -
+
P1.01-006 - Effect of EML-Alk Fusion Variant and Fusion Abundance on the Efficacy of Crizotinib in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tang Feng Lv | Author(s): Q. Zou, Yong Song
- Abstract
Loading... -
+
P1.01-007 - ALK Testing Trends and Patterns Among Community Practices in the United States
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): W. Wong, N. Wu, Laura Chu, K. Schulze, Matthew A Gubens
- Abstract
Loading... -
+
P1.01-008 - Real-World Patient Characteristics, Testing and Treatment Patterns of ALK+ NSCLC
09:30 - 09:30 | Presenter: Matthew A Gubens | Author(s): W. Wong, N. Wu, Laura Chu, K. Schulze, Peter B Illei
- Abstract
Loading... -
+
P1.01-009 - Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Jin Kang | Author(s): H. Chen, X. Zhang, Qing Zhou, H. Tu, Yi-Long Wu, Jin -Ji Yang
- Abstract
Loading... -
+
P1.01-010 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC
09:30 - 09:30 | Presenter: Yangsi Li | Author(s): Benyuan Jiang, Jin -Ji Yang, X. Zhang, Z. Zhang, W. Zhong, Qing Zhou, H. Tu, Z. Wang, H. Chen, C. Xu, B. Wang, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-011 - Pattern of Care and Survival of ALK Rearranged Non-Small Cell Lung Cancer in Two Australian Referral Centres
09:30 - 09:30 | Presenter: Malinda Itchins | Author(s): S. Kao, S.A. Hayes, V.M. Howell, A.J. Gill, W.A. Cooper, R. O'Connell, S. Clarke, Nick Pavlakis
- Abstract
Loading... -
+
P1.01-012 - Ceritinib in Anaplastic Lymphoma Kinase (ALK)+ NSCLC Patients Pretreated With Only Crizotinib: ASCEND-1 Subgroup Analysis
09:30 - 09:30 | Presenter: Alice Shaw | Author(s): D. Kim, Ben J Solomon, Enriqueta Felip, Gregory J Riely, Martin Schuler, Daniel SW Tan, Laura Q Chow, D. Ross Camidge, P. Urban, C. Ortmann, I. Malet, R. Mehra
- Abstract
Loading... -
+
P1.01-013 - Patient-Reported Outcomes and Safety from the Phase III ALUR Study of Alectinib vs Chemotherapy in Pre-Treated ALK+ NSCLC
09:30 - 09:30 | Presenter: Julien Mazieres | Author(s): Silvia Novello, J. De Castro, Maria Rita Migliorino, Å. Helland, Rafal Dziadziuszko, Frank Griesinger, Jürgen Wolf, A. Zeaiter, A. Cardona, B. Balas, T. Karagiannis, M. Chlistalla, V. Smoljanovic, I. Oh
- Abstract
Loading... -
+
P1.01-014 - Feasibility of Liquid Biopsy Using Plasma and Platelets for Detection of ALK Rearrangements in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Cheol-Kyu Park | Author(s): H. Park, H. Cho, J. Lim, Y. Choi, In-Jae Oh, Young-Chul Kim
- Abstract
Loading... -
+
P1.01-015 - Crizotinib in ROS1 Rearranged or MET Deregulated Non-Small-Cell Lung Cancer (NSCLC): Final Results of the METROS Trial
09:30 - 09:30 | Presenter: Lorenza Landi | Author(s): R. Chiari, C. Dazzi, M. Tiseo, A. Chella, A. Delmonte, L. Bonanno, D.L. Cortinovis, F. De Marinis, G. Minuti, R. Buosi, A. Morabito, G. Spitaleri, C. Gridelli, P. Maione, Domenico Galetta, F. Barbieri, Francesco Grossi, Silvia Novello, R. Bruno, G. Alì, A. Proietti, G. Fontanini, A.M. Joseph, Lucio Crinò, Frederico Cappuzzo
- Abstract
Loading... -
+
P1.01-016 - Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib
09:30 - 09:30 | Presenter: Ben J Solomon | Author(s): J. Soria, Fiona Blackhall, Alice Shaw, D. Ross Camidge, D. Kim, Tony SK Mok, J. Fernandez-Banet, Z. Kan, S. Li, Y. Liu, S.N. Ho
- Abstract
Loading... -
+
P1.01-017 - ALK-Rearranged May Promote VTE by Increasing the Expression of TF in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Qiming Wang | Author(s): Y. Sen, H. Tang
- Abstract
Loading... -
+
P1.01-018 - Acquired Resistance to Crizotinib in Advanced NSCLC with De Novo MET Overexpression
09:30 - 09:30 | Presenter: Anna Li | Author(s): Jin -Ji Yang, X.C. Zhang, J. Su, Qing Zhou, H. Chen, Z. Xie, H. Tu, W. Zhong, Z. Wang, C. Xu, Z. Chen, H. Yan, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-019 - ALK+ Non-Small Cell Lung Cancer Treated with First Line Crizotinib: Patient Characteristics, Treatment Patterns, and Survival
09:30 - 09:30 | Presenter: Claudio Martín | Author(s): Andrés F. Cardona, Oscar Arrieta, O. Castillo-Fernandez, G. Oblitas, L. Corrales, L. Lupinacci, M.A. Pérez, L. Rojas, L. González, L. Chirinos, C. Ortíz, M. Lema, C. Vargas, C. Puparelli, H. Carranza, J. Otero, L. Ramirez-Tirado
- Abstract
Loading... -
+
P1.01-020 - Translocation ALK/EML4+ in Non-Squamous NSCLC Population and Crizotinib: What Can We Tell?
09:30 - 09:30 | Presenter: Ana Barroso | Author(s): N.C. Pereira, M. Dias, D. Coutinho, J. Pimenta, S. Campaínha, S. Conde
- Abstract
Loading... -
+
P1.01-021 - FISH and IHC Discordance in ALK Rearranged Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Akhil Kapoor | Author(s): V. Noronha, A. Joshi, Vijay Patil, R. Kaushal, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading... -
+
P1.01-022 - Prediction of Central Nervous System Progression During Crizotinib Treatment in ALK+ NSCLC Among Hispanics
09:30 - 09:30 | Presenter: Andrés F. Cardona | Author(s): A. Ruiz Patino, Claudio Martin, Oscar Arrieta, O. Castillo-Fernandez, G. Oblitas, L. Corrales, L. Lupinacci, M.A. Pérez, L. Rojas, L. González, L. Chirinos, C. Ortiz, M. Lema, C. Vargas, C. Puparelli, H. Carranza, J. Otero, Z.L. Zatarain-Barron
- Abstract
Loading... -
+
P1.01-023 - ALK-Positive NSCLC: A TMH Experience
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): V. Noronha, A. Joshi, Vijay Patil, Alok Goel, Akhil Kapoor, R. Kumar, A. Janu, A. Mahajan, K. Prabhash
- Abstract
Loading... -
+
P1.01-024 - Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India
09:30 - 09:30 | Presenter: Anuradha Choughule | Author(s): K. Prabhash, V. Naronha, Vijay Patil, A. Joshi, V. Hariniv, R. Prasad
- Abstract
Loading... -
+
P1.01-025 - Biomarker Testing in Advanced NSCLC: A Simulation-Based Assessment of Medical Oncologists
09:30 - 09:30 | Presenter: Tara Herrmann | Author(s): E. Hamarstrom, P. Fidias
- Abstract
Loading... -
+
P1.01-026 - Circulating miR-206 in Advanced Stage Lung Cancer Patients and Its Association with Cancer Cachexia
09:30 - 09:30 | Presenter: Noorwati Sutandyo | Author(s): R. Hariani, P.E. Wuyung, A. Mulawarman, R. Ramli, A. Rahmadi
- Abstract
Loading... -
+
P1.01-027 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse
09:30 - 09:30 | Presenter: Si-Yang Liu | Author(s): Z. Dong, C. Zhang, W. Zhong, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-028 - Characteristics of Cell Free DNA in Lung Cancer Patients
09:30 - 09:30 | Presenter: Tomonori Abe | Author(s): C. Nakashima, A. Sato, E. Sueoka, S. Kimura, N. Sueoka-Aragane
- Abstract
Loading... -
+
P1.01-029 - Lymphocyte Monocyte Ratio as a Prognostic Factor in Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tarkan Yetisyigit | Author(s): S. Seber
- Abstract
Loading... -
+
P1.01-030 - Predictive Biomarkers in Non-SmallCell Carcinoma and Their Clinical Association
09:30 - 09:30 | Presenter: Anurag Mehta
- Abstract
Loading... -
+
P1.01-031 - Utilization and Timing of Foundation Medicine (FMI) Testing in U.S. Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
09:30 - 09:30 | Presenter: Lisa Wang | Author(s): D. Page, A. Shewade, P. Lambert, B. Arnieri, W. Capra, M. Khorshid, T.I. Mughal, L. Gay, S. Foser
- Abstract
Loading... -
+
P1.01-032 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART)
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): Shun Lu, Ying Cheng, Jie Wang, Y. Wang, T. Wang, T. Yung, X. Su, F. Sun, L.T. Wang, Yi-Long Wu
- Abstract
Loading... -
+
P1.01-033 - Thrombogenic Biomarkers in Patients with NSCLC – Associations with Thrombosis, Progression, and Survival
09:30 - 09:30 | Presenter: Marliese Alexander | Author(s): David L Ball, Ben J Solomon, M.P. Macmanus, R. Manser, B. Riedel, D. Westerman, S.M. Evans, R. Wolfe, K. Burbury
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-036 - Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer
09:30 - 09:30 | Presenter: Jennifer C King | Author(s): A. Ciupek, T. Perloff, A. Blanchard, K. Mason, E. Blais, D. Halverson, J. Bender, S. Madhavan, E. Petricoin
- Abstract
Loading... -
+
P1.01-037 - Circulating Tumor DNA Clearance During Treatment Associates with Improved Progression-Free Survival
09:30 - 09:30 | Presenter: Shun Lu | Author(s): Yong Song, Z. Xie, Z. Zhu, Li Liu, Min Li, X. Dong, M. Jin, Jie Hu, C. Rao, G. Tong, D. Zheng, W. Zhao, Y. Chen, H. Han-Zhang, H. Xu, X. Mao, L. Zhang, H. Liu, J. Ye
- Abstract
Loading... -
+
P1.01-038 - Identification and Characterization of Circulating Tumor Cells from Lung Cancer Patients for Selecting Target Anticancer Drugs for Relapse
09:30 - 09:30 | Presenter: Bong-Seog Kim
- Abstract
Loading... -
+
P1.01-039 - Survival Impact of Next-Generation Sequencing in Lung Cancer
09:30 - 09:30 | Presenter: Smadar Geva | Author(s): A. Belilovski Rozenblum, M. Ilouze, L.C. Roisman, Elizabeth Dudnik, A. Zer, Nir Peled
- Abstract
Loading... -
+
P1.01-040 - Clinical Utility of Plasma-Based NGS for Advanced-Stage NSCLC Patients with Insufficient or Unavailable Tumor Tissue
09:30 - 09:30 | Presenter: Pilar Garrido | Author(s): J. Zugazagoitia, A. Gómez Rueda, S. Ponce, I. Ramos, C. Camps, D. Isla, Ó. Juan, Rosario García Campelo, J. De Castro, M. Trigo, E. Jantus-Lewintre, M. Palka, Luis Paz-Ares
- Abstract
Loading... -
+
P1.01-041 - Role of Re-Biopsy During Disease Progression Non-Small Cell Lung Cancer for Acquired Resistance Analysis and Directing Oncology Treatments
09:30 - 09:30 | Presenter: Masatoshi Kakihana | Author(s): J. Maeda, J. Matsubayashi, S. Maehara, M. Hagiwara, T. Okano, Naohiro Kajiwara, T. Ohira, T. Nagao, Norihiko Ikeda
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-043 - Molecular Testing for Non-Small Cell Lung Cancer in Latin American
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): J. Cé Coelho, F.Z. Caorsi, Clarissa Mathias, G. Werutsky
- Abstract
Loading... -
+
P1.01-044 - Detection of Circulating Tumor Cells Is Associated with Disease Burden in Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kostas Syrigos | Author(s): O. Fiste, D. Grapsa, E. Politaki, I. Stoupis, D. Mavroudis, S. Agelaki
- Abstract
Loading... -
+
P1.01-045 - Companion Diagnostic Tests for EGFR, ALK and ROS-1 vs NGS in Advanced NSCLC Patients - Which Is the Best in Terms of Cost and Effective?
09:30 - 09:30 | Presenter: Luciene Schluckebier | Author(s): R. Caetano, V. Aran, O.U. Garay, C.G. Ferreira
- Abstract
Loading... -
+
P1.01-046 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study
09:30 - 09:30 | Presenter: Lucheng Zhu | Author(s): Shirong Zhang, B. Xia, Xueqin Chen, Shenglin Ma
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-048 - Clinical Impact of EGFR Mutation on Brain Metastasis in NSCLC Patients: A Meta-Regression Analysis
09:30 - 09:30 | Presenter: Chien-Chung Lin | Author(s): S. Yang, Yi-Lin Wu, Wei-Yuan Chang, P. Su, X. Liao, W. Su
- Abstract
Loading... -
+
P1.01-049 - Conformity of EGFR Mutation Status Between Blood Plasma and Tumor Tissue Samples Among NSCLC Adenocarcinoma Patients, at Dr. H. A. Rotinsulu Lung Hospital. A Preliminary Study
09:30 - 09:30 | Presenter: Reza Kurniawan Tanuwihardja | Author(s): H. Roesmargono
- Abstract
Loading... -
+
P1.01-050 - Cost-Effectiveness of PDL1 Based Test-And-Treat Strategy with Pembrolizumab as the 1st Line Treatment for NSCLC in Hong Kong
09:30 - 09:30 | Presenter: Herbert H Loong | Author(s): M. Huang, C.K.H. Wong, L.K.S. Leung, T. Burke, S. Chandwani, A.Y.Y. Law, S.C. Tan
- Abstract
Loading... -
+
P1.01-051 - Nivolumab Versus Chemotherapy as Post-Platinum Therapy for Advanced Non-Small Cell Lung Cancer in a Real-world Setting
09:30 - 09:30 | Presenter: Edward Brian Garon | Author(s): M. Moezi, J. Chandler, D. Waterhouse, S. Wilks, D. Richards, M. Hussein, David R Spigel, V. Gunuganti, M.D. Danese, M. Gleeson, D. Lubeck, V. Burns, B. Korytowsky, C. Batenchuk, R. Jotte
- Abstract
Loading... -
+
P1.01-052 - Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: M. Ballinger | Author(s): Rodolfo Bordoni, F. Ciardiello, J. Von Pawel, D. Cortinovis, P. He, T. Karagiannis, A. Sandler, W. Yu, F. Felizzi, A. Rittmeyer
- Abstract
Loading... -
+
P1.01-053 - Italian Nivolumab Expanded Access Programme (EAP): Data from Patients with Advanced Non-Squamous NSCLC and Brain Metastases
09:30 - 09:30 | Presenter: Lucio Crinò | Author(s): P. Bidoli, P. Ulivi, E. Minenza, Enrico Cortesi, Marina Chiara Garassino, Frederico Cappuzzo, Francesco Grossi, G. Tonini, M.G. Sarobba, G. Pinotti, G. Numico, R. Samaritani, L. Ciuffreda, A. Frassoldati, M.B. Bregni, A. Santo, F. Piantedosi, A. Illiano, F. De Marinis, A. Delmonte
- Abstract
Loading... -
+
P1.01-054 - PD-L1 Expression in Patients with Non-Small Cell Lung Cancer According to Underlying Pulmonary Disease: A Retrospective Study
09:30 - 09:30 | Presenter: Sayaka Ohara | Author(s): A. Saihara, Y. Matsumoto, R. Furukawa, Yuri Taniguchi, A. Sato, M. Hojo, K. Usui
- Abstract
Loading... -
+
P1.01-055 - Spectrum of Early Progression in Advanced NSCLC Patients Treated with PD-1 Inhibitors: Identifying Markers for Poor Outcome
09:30 - 09:30 | Presenter: Mizuki Nishino | Author(s): A.E. Adeni, C.A. Lydon, H. Hatabu, Pasi A Jänne, F..S. Hodi, M.M. Awad
- Abstract
Loading... -
+
P1.01-056 - Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis
09:30 - 09:30 | Presenter: Tatiana I Ionova | Author(s): A.L. Arzumanyan, L.V. Bolotina, V.V. Breder, N.N. Buevich, A.S. Danilova, E.A. Filippova, A.L. Kornietskaya, M.M. Kramchaninov, E.K. Kushniruk, D.H. Latipova, D.A. Lipatova, O.A. Malova, F.V. Moiseenko, T.P. Nikitina, S.V. Orlov, R.V. Orlova, S.A. Protsenko, K.A. Sarantseva, D.L. Stroyakovsky, A.V. Zinkovskaya, K.K. Laktionov
- Abstract
Loading... -
+
P1.01-057 - Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: José Miguel Sánchez-Torres | Author(s): J. Rogado, V. Pacheco-Barcia, M.D. Fenor De La Maza, J.M. Serra, P. Toquero, B. Vera, B. Obispo, R. Mondéjar, A. Ballesteros, O. Donnay, R. Colomer
- Abstract
Loading... -
+
P1.01-058 - Real World Data with Nivolumab: Experience in Argentina
09:30 - 09:30 | Presenter: Claudio Martin | Author(s): L. Lupinacci, F. Perazzo, C. Bas, O. Carranza, C. Puparelli, R. Kowalyzyn, I. Magri, M. Varela, Eduardo Richardet, K. Vera, S. Foglia, I. Jerez, E. Aman, G. Martinengo, E. Batagel, A. Dri, Norma Pilnik, M. Roa, P. Mando, F. Tsou, G. Recondo, F. Cayol, F. Marcos, S. Sena, C. Bagnes, Jose Nicolas Minatta, M. Rizzo
- Abstract
Loading... -
+
P1.01-059 - Combination Pembrolizumab and Low Dose Weekly Carboplatin/Paclitaxel for Patients with Recurrent/Metastatic NSCLC and PS of 2
09:30 - 09:30 | Presenter: Tamjeed Ahmed | Author(s): P. Triozzi, S. Addo, M. Kooski, W. Petty, J. Ruiz, S.C. Grant, R. D'Agostino, M. Bonomi
- Abstract
Loading... -
+
P1.01-060 - Nivolumab after Progression to Platinum- Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Mariana López Flores | Author(s): P. Diz Taín, I. Delgado Sillero, L. Sánchez Cousido, A. López González, M. Pedraza Lorenzo, Á. Rodríguez Sánchez, C. Castañón López, B. Nieto Mangudo, F. García Casabal, L. De Sande González, A. García Palomo
- Abstract
Loading... -
+
P1.01-061 - The Efficacy and Safety of Anti-PD-1 in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Systematic Review
09:30 - 09:30 | Presenter: Mingyi Di
- Abstract
Loading... -
+
P1.01-062 - KRAS Mutations (KRAS-Mut) and antiPD1/PDL1 Therapy in a Cohort of Lung Cancer (LC) Patients (P). Experience from a Single Institution
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): T. Morán, L. Vila, I. Teruel, C. Erasun, L. Angelats, S. España, C. Marc, N. Garcia-Balaña, J.M. Velarde
- Abstract
Loading... -
+
P1.01-063 - Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): J. Cé Coelho, T. Rebelato, R. D'Avila, G. Geib, P.E. Rubini Liedke, R. Peres Pereira, G. Werutsky, S. Jobim De Azevedo
- Abstract
Loading... -
+
P1.01-064 - Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kohei Yamane | Author(s): K. Takeda, M. Yanai, N. Tanaka, H. Izumi, Tomohiro Sakamoto, K. Yamaguchi, A. Yamasaki, T. Igishi, S. Eiji
- Abstract
Loading... -
+
P1.01-065 - Treatment Beyond Progression with Nivolumab in Patients with Advanced Non-Squamous NSCLC: Results from the Italian Expanded Access Program
09:30 - 09:30 | Presenter: Enrico Cortesi | Author(s): Francesco Grossi, R. Chiari, G. Azzarello, R. Berardi, D. Tassinari, G. Palmiotti, C. Verusio, A. Ardizzoia, L. Fioretto, L. Livi, S. Giusti, A. Bearz, G.L. Ceresoli, F. Piantedosi, A. Frassoldati, E. Ricevuto, G. Fasola, P. Marchetti, G. Puppo
- Abstract
Loading... -
+
P1.01-066 - PDL-1 Expression of Tumor Cell, Macrophage, and Immune Cells on Pleural Effusion
09:30 - 09:30 | Presenter: Yen-Han Tseng | Author(s): C. Lai, Y. Tseng, Teh-Ying Chou, Y. Chen
- Abstract
Loading... -
+
P1.01-067 - Characteristics and Survival Rate of Non-Small Cell Lung Cancer in Patients 45 Years of Age or Younger
09:30 - 09:30 | Presenter: Noorwati Sutandyo | Author(s): E. Soeratman, A. Mulawarman, L. Sari
- Abstract
Loading... -
+
P1.01-068 - Impact of Case-Based CME on Physician Performance in the Diagnosis and Management of NSCLC
09:30 - 09:30 | Presenter: Elaine Hamarstrom | Author(s): Tara Herrmann, Jeffrey Crawford
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study
09:30 - 09:30 | Presenter: Joo-Hang Kim | Author(s): J. Lee, Sang-We Kim, Jin-Hyoung Kang, Dae Ho Lee, Byoung Chul Cho, N. Shiraishi, V. Strout, Keunchil Park
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.01-072 - Epithelial-To-Mesenchymal Transition (EMT) in Lung Cancer: Classic Reproduction
09:30 - 09:30 | Presenter: Huibin Liu | Author(s): M. Zhang, J. Han, J. Song, W. Qiao
- Abstract
Loading... -
+
P1.01-073 - Over-Expression of GGPPs Contributes to Tumor Metastasis and Correlates with Poor Prognosis of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yong Song | Author(s): Tang Feng Lv, X. Wang, W. Xu
- Abstract
Loading... -
+
P1.01-074 - Exosomal RNA-Profiling of Lung Pleural Effusions Identifies Adenocarcinoma Patients through Elevated miR-200 Expression
09:30 - 09:30 | Presenter: Per Hydbring | Author(s): L. De Petris, E. Branden, H. Koyi, M. Novak, L. Kanter, P. Hååg, J. Hurley, V. Tadigotla, J. Skog, K. Viktorsson, Simon Ekman, R. Lewensohn
- Abstract
Loading... -
+
P1.01-075 - Simultaneous Multiplex Profiling of Gene Fusions, METe14 Mutations and Immune Genes in Advanced NSCLC by NCounter Technology
09:30 - 09:30 | Presenter: Noemi Reguart | Author(s): Cristina Teixidó, A. Giménez-Capitán, N. Vilariño, A. Arcocha, P. Jares, S. Castillo, X. Bernal, S. Muñoz, Ramon Palmero, I. Sullivan, M. Marginet, N. Viñolas, D. Martinez, N. Baixeras, Miguel-Angel Molina-Vila, A. Prat
- Abstract
Loading... -
+
P1.01-076 - Comparison of PANA Mutyper and PNA Clamping for Detecting KRAS Mutations in Tumor Tissue, Cell Block and Pleural Effusion from Cancer
09:30 - 09:30 | Presenter: Chan Kwon Park | Author(s): Seung Joon Kim, Y.K. Kim
- Abstract
Loading... -
+
P1.01-077 - Oncogenic Potential of a Novel HER2 755PL In-Frame (HER2PL) Mutation in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Anya Maan-Yuh Lin | Author(s): C. Yang, J. Lin, James Chih-Hsin Yang, H. Wang
- Abstract
Loading... -
+
P1.01-078 - Longitudinal Studies of Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Undergoing First-Line Target Therapy
09:30 - 09:30 | Presenter: Lin Zhi Xuan | Author(s): J. Chern, S. Chang, H. Wen-Tsung
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P1.01-078b - Dose-Paiting Radiation with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Junchao Wang | Author(s): Q. Wang, T. Li
- Abstract
Loading...
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-001 - SLFN11 Expression in Early Stage Non-Small Cell Lung Cancer Predicts Benefit from Adjuvant Chemotherapy with Taxane and Platinum
09:30 - 09:30 | Presenter: Vamsidhar Velcheti | Author(s): S. Schwartz, F. Cecchi, Y. Tian, S. Sellappan, Charles M Rudin, John Poirier, T. Hembrough
- Abstract
Loading... -
+
P1.02-002 - Diagnostic Utility of MUC4 Expression to Differentiate Epithelioid Mesothelioma from Lung Adenocarcinoma and Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Vishwa Jeet Amatya | Author(s): A.S. Mawas, Kei Kushitani, Y. Kai, Y. Miyata, Morihito Okada, Y. Takeshima
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-004 - Long Non-Coding RNA XLOC_000090 Promotes Lung Cancer Migration Through Modulation of miR-4505
09:30 - 09:30 | Presenter: Bin Zhang | Author(s): H. Zhang, L. Gao, Dongsheng Yue, Z. Zhang, Chenguang Li, C. Wang
- Abstract
Loading... -
+
P1.02-005 - Solving the Interfering Problem of Tissue Embedding OCT Compound in Activity Based Multiplex Profiling of Tyrosine Kinase Substrates
09:30 - 09:30 | Presenter: Sven Hillinger | Author(s): S. Arni, C. Caviezel, Walter Weder
- Abstract
Loading... -
+
P1.02-006 - Arsenic Promotes Persistent Alterations in the Lung PiRNA Transcriptome to Target Epigenetic Pathways
09:30 - 09:30 | Presenter: Victor D Martinez | Author(s): K. Ng, Erin Anne Marshall, Adam Patrick Sage, Brenda C. Minatel, I. Jurisica, W.L. Lam
- Abstract
Loading... -
+
P1.02-007 - TP53 and DNA-Repair Gene Polymorphisms as Risk Factors for the Development of Advanced Lung Adenocarcinoma in Serbia
09:30 - 09:30 | Presenter: Jelena Spasic | Author(s): A. Krivokuca, B. Zaric, D. Radosavljevic, B. Perin, S. Radulovic, R. Jankovic, M. Cavic
- Abstract
Loading... -
+
P1.02-008 - Expression of Mismatch Repair Proteins Associates with Survival and Response to EGFR Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
09:30 - 09:30 | Presenter: Hsiang-Ling Ho | Author(s): Y. Yeh, W. Hsieh, Teh-Ying Chou
- Abstract
Loading... -
+
P1.02-009 - Accumulation of Mutations in Background Normal Lung Tissue Constitutes a Major Lung Cancer Risk
09:30 - 09:30 | Presenter: Emi Kubo | Author(s): H. Takeshima, S. Yamashita, N. Motoi, T. Ushijima
- Abstract
Loading... -
+
P1.02-010 - Novel Role of hSSB2 in the Base Excision Repair Pathway (BER)
09:30 - 09:30 | Presenter: Mark Adams | Author(s): A. Naqi, M. Fisher, S. Beard, J. Burgess, Kenneth Obyrne, D. Richard
- Abstract
Loading... -
+
P1.02-011 - XRCC6BP1: A Key Player in the DNA Repair of Cisplatin Resistant NSCLC Cells
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): S. Singh, R. Farrell, E. Foley, Y. He, L. Brady, V. Young, R. Ryan, S. Nicholson, N. Leonard, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P1.02-012 - Profiling DNA Repair in Lung Cancer
09:30 - 09:30 | Presenter: Alexander Dobrovic | Author(s): H. Do, G. Wright
- Abstract
Loading... -
+
P1.02-013 - ATM Mutation as a Predictor for Mutation Burden in NSCLC
09:30 - 09:30 | Presenter: D. Gwyn Bebb | Author(s): L.F. Petersen
- Abstract
Loading... -
+
P1.02-014 - TGFalpha Promotes Growth of Lung Tumors Carrying EGFR Mutation but not KRAS Mutation in Transgenic Mouse Models in Vivo
09:30 - 09:30 | Presenter: Koichi Tomoshige | Author(s): G. Minzhe, T. Tsuchiya, T. Fukazawa, Y. Naomoto, T. Nagayasu, Y. Maeda
- Abstract
Loading... -
+
P1.02-015 - Comparison of Study Models of Lung Cancer
09:30 - 09:30 | Presenter: Yoshito Yamada | Author(s): J. Jang, F. Janker, Walter Weder, W. Jungraithmayr
- Abstract
Loading... -
+
P1.02-016 - Establishment of Lung Adenocarcinoma Organoid Cultures
09:30 - 09:30 | Presenter: Hirotsugu Notsuda | Author(s): N. Radulovich, C. Ng, L. Tamblyn, M. Cabanero, M. Li, N. Pham, Ming Sound Tsao
- Abstract
Loading... -
+
P1.02-017 - Freely Floating Cancer Cells in Lymph Node Sinuses of Hilar Lymph Node Positive Lung Cancer Patients
09:30 - 09:30 | Presenter: Yusuke Nakamura | Author(s): M. Mukai, S. Hiraiwa, K. Kishima, T. Sugiyama, T. Tajiri, S. Yamada, M. Iwazaki
- Abstract
Loading... -
+
P1.02-018 - Number of Cancer Cells in Lung Adenocarcinoma Specimen – Correlation with Noguchi's Classification, WHO Pathologic Type, and Prognosis
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): Y. Nakazato, M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading... -
+
P1.02-019 - Dual Role of Notch in Lung Cancer
09:30 - 09:30 | Presenter: Sara Sinicropi-Yao | Author(s): J. Amann, K. Coombes, David P Carbone
- Abstract
Loading... -
+
P1.02-020 - Acinar-Predominant Pattern Correlates with Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung
09:30 - 09:30 | Presenter: Gengpeng Lin | Author(s): H. Li, C. Xie
- Abstract
Loading... -
+
P1.02-021 - Can 18F-FDG PET/CT Predict the Pathological Necrosis and Microvessel Density in Lung Adenocarcinomas
09:30 - 09:30 | Presenter: Young Wha Koh | Author(s): S.J. Lee, S.Y. Park
- Abstract
Loading... -
+
P1.02-022 - Spontaneous Regression of Primary Pulmonary Synovial Sarcoma; A Case Report
09:30 - 09:30 | Presenter: Naoko Miyata | Author(s): H. Tsunezuka, N. Ishikawa, T. Furuya, C. Nakazono, S. Ishihara, Satoru Okada, D. Kato, Junichi Shimada, E. Konishi, M. Inoue
- Abstract
Loading... -
+
P1.02-023 - TGF-β Signaling Mediated by Fibroblasts is Associated with the Histological Subtypes of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Ryo Sato | Author(s): T. Semba, H. Ichiyasu, K. Fujii, Hideyuki Saya, Y. Arima
- Abstract
Loading... -
+
P1.02-024 - Correlation of Maximal Tumor Diameter between Pathology Specimen and CT in Nonsmall Cell Lung Cancer: A Pilot Study
09:30 - 09:30 | Presenter: Heae Surng Park | Author(s): C.H. Park, S. Lee, T.H. Kim
- Abstract
Loading... -
+
P1.02-025 - A Case of Primary Peripheral Epithelial–Myoepithelial Carcinoma of the Lung
09:30 - 09:30 | Presenter: Daisuke Eriguchi | Author(s): H. Takahashi, O. Uchida, Eiji Nakajima, T. Tanaka, K. Murakami, Norihiko Ikeda
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-027 - Minute Pulmonary Meningothelial-Like Nodules Presenting as Multiple Ground-Glass Density Nodules (GGNs): A Case Report
09:30 - 09:30 | Presenter: Yeon Bi Han | Author(s): Hyun Jung Kwon, E. Park, H. Kim, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.02-028 - Pathways Involved in Early Stage Lung Cancers
09:30 - 09:30 | Presenter: Vilde D Haakensen | Author(s): S. Nygårad, V. Nygaard, L.H. Jørgensen, S. Solberg, E. Hovig, O.T. Brustugun, O.C. Lingjærde, Å. Helland
- Abstract
Loading... -
+
P1.02-029 - Pulmonary Adenofibroma with Cystic Change: A Case Report
09:30 - 09:30 | Presenter: Eunhyang Park | Author(s): Y.B. Han, H.J. Kwon, H. Kim, Jin-Haeng Chung
- Abstract
Loading... -
+
P1.02-030 - The Effect of Chronic Obstructive Pulmonary Disease on the Tumor Stroma in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yasuhiko Ohshio | Author(s): K. Hayashi, K. Okamoto, R. Kaku, Yoko Kataoka, Y. Kawaguchi, M. Ohshio, Tomoyuki Igarashi, M. Hashimoto, Koji Teramoto, J. Hanaoka
- Abstract
Loading... -
+
P1.02-031 - Clinicopathological Study of 16 Cases with Pulmonary Pleomorphic Carcinoma
09:30 - 09:30 | Presenter: Fumi Ohsawa | Author(s): M. Kamiyoshihara, Hitoshi Igai, Takashi Ibe, Ryohei Yoshikawa
- Abstract
Loading... -
+
P1.02-032 - Clinicopathological Profile of Invasive Mucinous Adenocarcinoma Based on Evaluation of Invasive Components
09:30 - 09:30 | Presenter: Yuichi Mitsui | Author(s): H. Fushimi, Y. Tanio, K. Ueno, J. Uchida, M. Suzuki, Y. Shirai, K. Matsumoto, K. Kuno, T. Yanase, Y. Funakoshi, H. Takabatake, K. Shimazu, A. Kikuyama
- Abstract
Loading... -
+
P1.02-033 - Differentiating of Cytomorphological Characteristics in Non-Small Cell Lung Cancer Predicts Value of Radiologic Features
09:30 - 09:30 | Presenter: Ryota Tanaka | Author(s): M. Fujiwara, K. Tachibana, J. Miura, R. Shimizu, Y. Nagashima, T. Miya, H. Takei, J. Shibahara, H. Kamma, H. Kondo
- Abstract
Loading... -
+
P1.02-034 - Non-Invasive Qualitative Diagnosis of Lung Cancer Enabled by Spectrum Analysis of Ultrasound
09:30 - 09:30 | Presenter: Takashi Anayama | Author(s): R. Ihara, T. Aoki, E. Narukami, Takahiro Nakajima, Hironobu Wada, Kentaro Hirohashi, R. Miyazaki, Kazuhiro Yasufuku, K. Orihashi
- Abstract
Loading... -
+
P1.02-035 - Human Papillomavirus Infection in Lung Squamous Cell Carcinoma and Correlation to p16 INK4a Expression from an Argentine Population
09:30 - 09:30 | Presenter: Valeria Cecilia Denninghoff | Author(s): M.M. García Falcone, M.T. Cuello, A.J. Garcia, G.(. Recondo, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P1.02-036 - Fine Needle Aspiration as a Diagnostic Tool in Lung Cancer: Worth Pursuing?
09:30 - 09:30 | Presenter: Luiz H. Araujo | Author(s): E.T. Cunha, A.M.C. Sousa, H. Paiva, F. Rodrigues, M.T. Accioly, L. Bastos, C.F. Silva, N. Carvalho, C.A.M. Sousa, I. Small, C.G. Ferreira
- Abstract
Loading... -
+
P1.02-037 - Pulmonary Carcinoid Tumors: A Prognostic Implications of Ki-67 Proliferative Index
09:30 - 09:30 | Presenter: Renata Langfort | Author(s): Piotr Rudzinski, E. Szczepulska, B. Maksymiuk, T. Orlowski, M. Szolkowska
- Abstract
Loading... -
+
P1.02-038 - Bilateral Combined Lymphangioleiomyomatosis and Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia with Typical Carcinoids
09:30 - 09:30 | Presenter: Jan Hinrich Von Der Thüsen | Author(s): P. Atmodimedjo, E. Dubbink, J. Miedema, W. Dinjens
- Abstract
Loading... -
+
P1.02-039 - Preventive and Therapeutic Action of Id1 Inhibition in KRAS-Mutant (KM) Lung Adenocarcinoma (LAC) Tumors in a Xenograft Murine Model
09:30 - 09:30 | Presenter: Marta Roman Moreno | Author(s): S. Vicent, I. López, I. Baraibar, J. Jang, Christian Rolfo, Ignacio Gil-Bazo
- Abstract
Loading... -
+
P1.02-040 - Genetic Risk Evaluation in Families with Lung Cancer History in High Lung Cancer Mortality Region of Xuanwei, China
09:30 - 09:30 | Presenter: Madiha Kanwal | Author(s): X. Ding, M. Zhanshan, P. Wang, H. Yun-Chao, C. Yi
- Abstract
Loading... -
+
P1.02-041 - Mutation of SWI/SNF Complex Genes Is Frequent in Poorly Differentiated, Mesenchymal-Like Lung Cancer without Major Driver Mutation
09:30 - 09:30 | Presenter: Taichiro Yoshimoto | Author(s): Daisuke Matsubara, Toshiro Niki
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-044 - Relationship between RET Rearrangement and Thymidylate Synthase mRNA Expression in Non-Small Cell Lung Cancer Tissues
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Tian, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-045 - PIK3CA Mutations in Chinese Patients with Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): B. Wu, Chunwei Xu, W. Wang, Xiaobing Zheng, Wu Zhuang, Z. Song, G. Lin, X. Chen, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-046 - Mutational Subtypes and Prognosis of Non-Small-Cell Lung Cancer Harboring HER2 Mutations
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Huang, Z. Song, Y. Chen, W. Liu, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-047 - Mutational Features and Prognosis of Non-Small-Cell Lung Cancer Harboring RAS Mutations
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Y. Zhu, Chunwei Xu, W. Wang, X. Liao, Wu Zhuang, Z. Song, Y. Chen, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-048 - Somatic Mutation Analysis of RB1 Gene in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-049 - Detection of CDKN2A Gene Mutations in Patients with Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): S. Wang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-050 - Pan-Can Analysis of miRNAs at the Imprinted Chromosome 14q32 Locus Reveals a Unique Pattern of Deregulation in NSCLC
09:30 - 09:30 | Presenter: Jhon Ralph Enterina | Author(s): W.L. Lam
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-052 - Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma
09:30 - 09:30 | Presenter: Masatsugu Kuraoka | Author(s): Vishwa Jeet Amatya, Kei Kushitani, A.S. Mawas, Y. Miyata, Morihito Okada, T. Kishimoto, K. Inai, T. Nishisaka, T. Sueda, Y. Takeshima
- Abstract
Loading... -
+
P1.02-053 - A New Strategy of Adjuvant Chemotherapy for Lung Cancer Based on the Expression of Anti-Aging Gene Klotho
09:30 - 09:30 | Presenter: Kyoshiro Takegahara | Author(s): Jitsuo Usuda, T. Inoue, T. Sonokawa
- Abstract
Loading... -
+
P1.02-054 - The Molecular Characterisation of Lung Adenocarcinoma Subgroups
09:30 - 09:30 | Presenter: Elizabeth Starren | Author(s): S. Willis-Owen, S.K. Lo, Andrew G Nicholson, W. Cookson, M. Moffatt
- Abstract
Loading... -
+
P1.02-055 - Genotyping Squamous Cell Lung Carcinoma Among Hispanics (Geno1.1-CLICaP)
09:30 - 09:30 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, L. Rojas, Z.L. Zatarain-Barron, L. Corrales, Claudio Martin, J. Rodriguez, J. Rodriguez, P. Archila, Alejandro Ruiz-Patiño, Rafael Rosell
- Abstract
Loading... -
+
P1.02-056 - BRAF Non-V600E Mutations Recurrently Found in Non-Small Cell Lung Cancer in Chinese Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Q. Xu, W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Z. Xu, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-057 - Analysis of C-MET Amplification Non-Small Cell Lung Cancer Cell Blocks from Pleural Effusion
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Y. Tian, J. Xu, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P1.02-058 - Molecular Characteristics and Outcome of Chinese Patients with Non-Small Cell Lung Cancer Harboring NFE2L2 Mutations
09:30 - 09:30 | Presenter: Gang Chen | Author(s): W. Wang, Chunwei Xu, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.02-060 - Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung
09:30 - 09:30 | Presenter: Yohei Yurugi | Author(s): W. Fujiwara, Y. Kidokoro, K. Hosoya, T. Ohno, T. Sakabe, Yasuaki Kubouchi, M. Wakahara, Y. Takagi, T. Haruki, K. Nosaka, K. Miwa, K. Araki, Y. Taniguchi, T. Shiomi, H. Nakamura, Y. Umekita
- Abstract
Loading... -
+
P1.02-061 - Podoplanin Expression in Cancer-Associated Fibroblasts Predicts Unfavourable Prognosis in Patients with Stage IA Adenocarcinoma
09:30 - 09:30 | Presenter: Yasuaki Kubouchi | Author(s): W. Fujiwara, Y. Kidokoro, T. Ohno, Yohei Yurugi, M. Wakahara, Y. Takagi, K. Miwa, K. Araki, Y. Taniguchi, H. Nakamura, Y. Umekita
- Abstract
Loading... -
+
P1.02-062 - Ring Finger Protein 38 Promote Non-Small Cell Lung Cancer Progression by Endowing Cell EMT Phenotype
09:30 - 09:30 | Presenter: Jian-Yong Ding | Author(s): C. Jin, D. Xiong
- Abstract
Loading... -
+
P1.02-063 - Tumor Heterogeneity Analyses by Integrated Proteo-Genomics of Thoracic Tumors from Sequential Biopsies and Warm Autopsies
09:30 - 09:30 | Presenter: Udayan Guha | Author(s): N. Roper, X. Zhang, T.K. Maity, S. Gao, A. Venugopalan, R. Biswas, C.M. Cultraro, C. Kim, E. Padiernos, A. Rajan, Anish Thomas, R. Hassan, D. Kleiner, S. Hewitt, J. Khan
- Abstract
Loading... -
+
P1.02-064 - Proteomic Analysis of Exosome Purified Using a Novel Reagent
09:30 - 09:30 | Presenter: Ayako Kurimoto | Author(s): T. Inuzuka
- Abstract
Loading... -
+
P1.02-065 - Histone Deacetylase Inhibition Alters Stem Cell Phenotype in Gefitinib-Resistant Lung Cancer Cells with EGFR Mutation
09:30 - 09:30 | Presenter: Fariz Nurwidya | Author(s): F. Takahashi, Moulid Hidayat, I. Kobayashi, Aditya Wirawan, M. Kato, K. Tajima, N. Shimada, I. Takeda, M. Tajima, N. Matsumoto, K. Kanemori, Y. Koinuma, F. Yunus, Sita Andarini, K. Takahashi
- Abstract
Loading... -
+
P1.02-066 - Cancer Stem Cells in Pulmonary High Grade Neuroendocrine Carcinoma: a Series of 23 Cases from Eastern India
09:30 - 09:30 | Presenter: Prasanta Raghab Mohapatra | Author(s): S. Patra, P. Mishra, S. Purkait, M. Sable, S. Padhi, M. Sethy, N. Sahoo, M. Nayak, R. Gharei, S. Bhuniya, M.K. Panigrahi
- Abstract
Loading... -
+
P1.02-067 - FGF1 and IGF1 Co-Stimulation Promoted the Amplification and Cancer Stemness of Lung Cancer Cells under 3D Culture Condition
09:30 - 09:30 | Presenter: Rui Zhang
- Abstract
Loading... -
+
P1.02-068 - Effects of Pirfenidone Targeting EMT and Tumor-Stroma Interaction as Novel Treatment for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Ayako Fujiwara | Author(s): Yasushi Shintani, S. Funaki, T. Kawamura, Ryu Kanzaki, E. Fukui, M. Minami, Meinoshin Okumura
- Abstract
Loading... -
+
P1.02-069 - Pemetrexed-Resistant Non-Small Cell Lung Cancer Cell Lines Have Novel Drug-Resistant Mechanisms
09:30 - 09:30 | Presenter: Ryosuke Tanino | Author(s): Y. Tsubata, N. Harashima, M. Harada, T. Isobe
- Abstract
Loading... -
+
P1.02-070 - Identification of Lung Cancer Specific Differentially Methylated Regions Using Genome-Wide DNA Methylation Study
09:30 - 09:30 | Presenter: Yoonki Hong
- Abstract
Loading... -
+
P1.02-071 - SFN Stabilizes Oncoproteins through Binding with SKP1 to Block SCFFBW7 Ubiquiting Ligase
09:30 - 09:30 | Presenter: Jeongmin Hong | Author(s): Aya Shiba, Y. Kim, M. Noguchi
- Abstract
Loading... -
+
P1.02-071a - Targeting Human Single Stranded DNA Binding Protein (hSSB) 1, a Novel Prognostic Factor, in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): D. Boucher, N. Ashton, J. Burgess, E. Bolderson, Martin P Barr, Steven G. Gray, K. Gately, L. Croft, D. Richard
- Abstract
Loading... -
+
P1.02-071b - SASH1 Is a Prognostic Indicator and Future Target in NSCLC
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): J. Burgess, E. Bolderson, Mark Adams, S. Zhang, S. Fox, G. Wright, R. Young, Ben J Solomon, Martin P Barr, Steven G. Gray, D. Richard
- Abstract
Loading...